ReP USP - Resultado da busca

Artigo de periodico
Kombucha tea improves glucose tolerance and reduces hepatic steatosis in obese mice (2022)
Moreira, Gabriele R; Araujo, Layanne Cabral da Cunha ; Murata, Gilson Masahiro ; Matos, Sandro Leão; Carvalho, Carla Roberta de Oliveira
Source: Biomedicine & Pharmacotherapy. Unidades: FM, ICB, FMRP
Subjects: FISIOLOGIA, MODELOS ANIMAIS DE DOENÇAS, CAMUNDONGOS, HEPATOPATIAS, BEBIDAS ISOTÔNICAS, RESISTÊNCIA À INSULINA, OBESIDADE, INTESTINO DE ANIMAL, FÍGADO, HOMEOSTASE, PROBIÓTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOREIRA, Gabriele R et al. Kombucha tea improves glucose tolerance and reduces hepatic steatosis in obese mice. Biomedicine & Pharmacotherapy, v. 155, p. 1-10, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.biopha.2022.113660. Acesso em: 24 dez. 2024.
APA
Moreira, G. R., Araujo, L. C. da C., Murata, G. M., Matos, S. L., & Carvalho, C. R. de O. (2022). Kombucha tea improves glucose tolerance and reduces hepatic steatosis in obese mice. Biomedicine & Pharmacotherapy, 155, 1-10. doi:10.1016/j.biopha.2022.113660
NLM
Moreira GR, Araujo LC da C, Murata GM, Matos SL, Carvalho CR de O. Kombucha tea improves glucose tolerance and reduces hepatic steatosis in obese mice [Internet]. Biomedicine & Pharmacotherapy. 2022 ; 155 1-10.[citado 2024 dez. 24 ] Available from: https://doi.org/10.1016/j.biopha.2022.113660
Vancouver
Moreira GR, Araujo LC da C, Murata GM, Matos SL, Carvalho CR de O. Kombucha tea improves glucose tolerance and reduces hepatic steatosis in obese mice [Internet]. Biomedicine & Pharmacotherapy. 2022 ; 155 1-10.[citado 2024 dez. 24 ] Available from: https://doi.org/10.1016/j.biopha.2022.113660
Artigo de periodico
Lipoatrophy-associated insulin resistance and hepatic steatosis are attenuated by intake of diet rich in omega 3 fatty acids (2020)
Moreira, Rafael Junges; Castro, Érique de ; Silva, Tiago Eugênio Oliveira da; Oliveira, Thiago Belchior de; Peixoto, Albert Souza ; Chaves Filho, Adriano de Britto; Moreno, Mayara Franzoi ; Lima, Janayna Dias; Yoshinaga, Marcos Yukio ; Miyamoto, Sayuri ; Morais, Mychel Raony Paiva Teixeira; Zorn, Telma Maria Tenório; Cogliati, Bruno ; Iwai, Leo Kei; Palmisano, Giuseppe ; Cabral, Fernanda Janku; Festuccia, William Tadeu Lara
Source: Molecular Nutrition & Food Research. Unidades: IQ, ICB, FMVZ
Subjects: FISIOLOGIA, BIOLOGIA CELULAR, PARASITOLOGIA, RESISTÊNCIA À INSULINA, ÁCIDOS GRAXOS, INGESTÃO, HOMEOSTASE, GLICOSE, HEPATOPATIAS, FÍGADO GORDUROSO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOREIRA, Rafael Junges et al. Lipoatrophy-associated insulin resistance and hepatic steatosis are attenuated by intake of diet rich in omega 3 fatty acids. Molecular Nutrition & Food Research, p. 13 , 2020Tradução . . Disponível em: https://doi.org/10.1002/mnfr.201900833. Acesso em: 24 dez. 2024.
APA
Moreira, R. J., Castro, É. de, Silva, T. E. O. da, Oliveira, T. B. de, Peixoto, A. S., Chaves Filho, A. de B., et al. (2020). Lipoatrophy-associated insulin resistance and hepatic steatosis are attenuated by intake of diet rich in omega 3 fatty acids. Molecular Nutrition & Food Research, 13 . doi:10.1002/mnfr.201900833
NLM
Moreira RJ, Castro É de, Silva TEO da, Oliveira TB de, Peixoto AS, Chaves Filho A de B, Moreno MF, Lima JD, Yoshinaga MY, Miyamoto S, Morais MRPT, Zorn TMT, Cogliati B, Iwai LK, Palmisano G, Cabral FJ, Festuccia WTL. Lipoatrophy-associated insulin resistance and hepatic steatosis are attenuated by intake of diet rich in omega 3 fatty acids [Internet]. Molecular Nutrition & Food Research. 2020 ; 13 .[citado 2024 dez. 24 ] Available from: https://doi.org/10.1002/mnfr.201900833
Vancouver
Moreira RJ, Castro É de, Silva TEO da, Oliveira TB de, Peixoto AS, Chaves Filho A de B, Moreno MF, Lima JD, Yoshinaga MY, Miyamoto S, Morais MRPT, Zorn TMT, Cogliati B, Iwai LK, Palmisano G, Cabral FJ, Festuccia WTL. Lipoatrophy-associated insulin resistance and hepatic steatosis are attenuated by intake of diet rich in omega 3 fatty acids [Internet]. Molecular Nutrition & Food Research. 2020 ; 13 .[citado 2024 dez. 24 ] Available from: https://doi.org/10.1002/mnfr.201900833
Artigo de periodico
Dual SGLT1/SGLT2 inhibitor phlorizin ameliorates non-alcoholic fatty liver disease and hepatic glucose production in type 2 diabetic mice (2020)
Silva, Aline David; Esteves, João Victor Del Conti ; Morais, Mychel Raony Paiva Teixeira ; Freitas, Helayne Soares ; Zorn, Telma Maria Tenório; Giannella, Maria Lucia Cardillo Correa ; Machado, Ubiratan Fabres
Source: Diabetes, Metabolic Syndrome and Obesity. Unidades: ICB, FM
Subjects: FISIOLOGIA, BIOLOGIA CELULAR, DIABETES MELLITUS, GLICOSE, GLICEMIA, HOMEOSTASE, CAMUNDONGOS, INFLAMAÇÃO, HEPATOPATIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Aline David et al. Dual SGLT1/SGLT2 inhibitor phlorizin ameliorates non-alcoholic fatty liver disease and hepatic glucose production in type 2 diabetic mice. Diabetes, Metabolic Syndrome and Obesity, v. 2020, p. 739—751, 2020Tradução . . Disponível em: https://doi.org/10.2147/DMSO.S242282. Acesso em: 24 dez. 2024.
APA
Silva, A. D., Esteves, J. V. D. C., Morais, M. R. P. T., Freitas, H. S., Zorn, T. M. T., Giannella, M. L. C. C., & Machado, U. F. (2020). Dual SGLT1/SGLT2 inhibitor phlorizin ameliorates non-alcoholic fatty liver disease and hepatic glucose production in type 2 diabetic mice. Diabetes, Metabolic Syndrome and Obesity, 2020, 739—751. doi:10.2147/DMSO.S242282
NLM
Silva AD, Esteves JVDC, Morais MRPT, Freitas HS, Zorn TMT, Giannella MLCC, Machado UF. Dual SGLT1/SGLT2 inhibitor phlorizin ameliorates non-alcoholic fatty liver disease and hepatic glucose production in type 2 diabetic mice [Internet]. Diabetes, Metabolic Syndrome and Obesity. 2020 ; 2020 739—751.[citado 2024 dez. 24 ] Available from: https://doi.org/10.2147/DMSO.S242282
Vancouver
Silva AD, Esteves JVDC, Morais MRPT, Freitas HS, Zorn TMT, Giannella MLCC, Machado UF. Dual SGLT1/SGLT2 inhibitor phlorizin ameliorates non-alcoholic fatty liver disease and hepatic glucose production in type 2 diabetic mice [Internet]. Diabetes, Metabolic Syndrome and Obesity. 2020 ; 2020 739—751.[citado 2024 dez. 24 ] Available from: https://doi.org/10.2147/DMSO.S242282
Artigo de periodico
The hepatokine Tsukushi is released in response to NAFLD and impacts cholesterol homeostasis (2019)
Mouchiroud, Mathilde ; Camiré, Étienne; Aldow, Manal; Caron, Alexandre ; Jubinville, Éric; Turcotte, Laurie; Kaci, Inès; Beaulieu, Marie-Josée; Roy, Christian; Labbé, Sébastien M.; Varin, Thibault V.; Gélinas, Yves; Lamothe, Jennifer; Trottier, Jocelyn; Mitchell, Patricia L.; Guénard, Frédéric ; Festuccia, William Tadeu Lara ; Joubert, Philippe ; Rose, Christopher F. ; Karvellas, Constantine J.; Barbier, Oliver ; Morissette, Mathieu C.; Marette, André; Laplante, Mathieu
Source: Journal of clinical investigation insight. Unidade: ICB
Subjects: FISIOLOGIA, HOMEOSTASE, COLESTEROL, OBESIDADE, ARTERIOSCLEROSE, INSUFICIÊNCIA HEPÁTICA, DISLIPIDEMIAS, HEPATOPATIAS, CAMUNDONGOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOUCHIROUD, Mathilde et al. The hepatokine Tsukushi is released in response to NAFLD and impacts cholesterol homeostasis. Journal of clinical investigation insight, v. 4, n. 15, p. 17 , 2019Tradução . . Disponível em: https://doi.org/10.1172/jci.insight.129492. Acesso em: 24 dez. 2024.
APA
Mouchiroud, M., Camiré, É., Aldow, M., Caron, A., Jubinville, É., Turcotte, L., et al. (2019). The hepatokine Tsukushi is released in response to NAFLD and impacts cholesterol homeostasis. Journal of clinical investigation insight, 4( 15), 17 . doi:10.1172/jci.insight.129492
NLM
Mouchiroud M, Camiré É, Aldow M, Caron A, Jubinville É, Turcotte L, Kaci I, Beaulieu M-J, Roy C, Labbé SM, Varin TV, Gélinas Y, Lamothe J, Trottier J, Mitchell PL, Guénard F, Festuccia WTL, Joubert P, Rose CF, Karvellas CJ, Barbier O, Morissette MC, Marette A, Laplante M. The hepatokine Tsukushi is released in response to NAFLD and impacts cholesterol homeostasis [Internet]. Journal of clinical investigation insight. 2019 ; 4( 15): 17 .[citado 2024 dez. 24 ] Available from: https://doi.org/10.1172/jci.insight.129492
Vancouver
Mouchiroud M, Camiré É, Aldow M, Caron A, Jubinville É, Turcotte L, Kaci I, Beaulieu M-J, Roy C, Labbé SM, Varin TV, Gélinas Y, Lamothe J, Trottier J, Mitchell PL, Guénard F, Festuccia WTL, Joubert P, Rose CF, Karvellas CJ, Barbier O, Morissette MC, Marette A, Laplante M. The hepatokine Tsukushi is released in response to NAFLD and impacts cholesterol homeostasis [Internet]. Journal of clinical investigation insight. 2019 ; 4( 15): 17 .[citado 2024 dez. 24 ] Available from: https://doi.org/10.1172/jci.insight.129492
Artigo de periodico
Uncaria tomentosa improves insulin sensitivity and inflammation in experimental NAFLD (2018)
Araujo, Layanne Cabral da Cunha ; Feitosa, Karla Barroso; Murata, Gilson Masahiro ; Furigo, Isadora Clivatti ; Teixeira, Simone Aparecida ; Monaco, Camila Ferraz Lucena ; Ribeiro, Luciene Maria; Muscará, Marcelo Nicolás (Orientador) ; Costa, Soraia Katia Pereira ; Donato Junior, José ; Bordin, Silvana ; Curi, Rui ; Carvalho, Carla Roberta de Oliveira
Source: Scientific reports. Unidade: ICB
Subjects: PLANTAS MEDICINAIS, HEPATOPATIAS, INSULINA, EXTRATOS (FORMAS FARMACÊUTICAS), GLICOSE, CAMUNDONGOS, HOMEOSTASE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARAUJO, Layanne Cabral da Cunha et al. Uncaria tomentosa improves insulin sensitivity and inflammation in experimental NAFLD. Scientific reports, v. 8, 2018Tradução . . Disponível em: https://doi.org/10.1038/s41598-018-29044-y. Acesso em: 24 dez. 2024.
APA
Araujo, L. C. da C., Feitosa, K. B., Murata, G. M., Furigo, I. C., Teixeira, S. A., Monaco, C. F. L., et al. (2018). Uncaria tomentosa improves insulin sensitivity and inflammation in experimental NAFLD. Scientific reports, 8. doi:10.1038/s41598-018-29044-y
NLM
Araujo LC da C, Feitosa KB, Murata GM, Furigo IC, Teixeira SA, Monaco CFL, Ribeiro LM, Costa SKP, Donato Junior J, Bordin S, Curi R, Carvalho CR de O. Uncaria tomentosa improves insulin sensitivity and inflammation in experimental NAFLD [Internet]. Scientific reports. 2018 ; 8[citado 2024 dez. 24 ] Available from: https://doi.org/10.1038/s41598-018-29044-y
Vancouver
Araujo LC da C, Feitosa KB, Murata GM, Furigo IC, Teixeira SA, Monaco CFL, Ribeiro LM, Costa SKP, Donato Junior J, Bordin S, Curi R, Carvalho CR de O. Uncaria tomentosa improves insulin sensitivity and inflammation in experimental NAFLD [Internet]. Scientific reports. 2018 ; 8[citado 2024 dez. 24 ] Available from: https://doi.org/10.1038/s41598-018-29044-y

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Subjects

Funding Agencies

Indexado em

Non normalized affiliation